Education
About Us
Working with TipRanks
Follow Us
Douglas Norman Deeth Insider Profile
4 Followers
Douglas Norman Deeth, Director at ADVANZ PHARMA, holds 2.50K shares in Cipher Pharmaceuticals (Ticker: CPHRF), holds 11.54K shares in ADVANZ PHARMA (Ticker: CXRXF).
Douglas Norman Deeth ADVANZ PHARMA (CXRXF)Director
ADVANZ PHARMA (CXRXF)
Director
Not Ranked
Douglas Norman Deeth has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Douglas Norman Deeth's holdings
Insider Roles
Director
Roles that Douglas Norman Deeth holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Douglas Norman Deeth
Douglas Norman Deeth's Trading History
ADVANZ PHARMA
Jan 25, 2016
―
Uninformative Sell
―
$197.72K
Cipher Pharmaceuticals
Sep 16, 2025
Director
Uninformative Sell
40.90K
$25.63K
List of latest transactions for each holding click on a transaction to see Douglas Norman Deeth's performance on stock
You May Also Like
Douglas Norman Deeth insider profile FAQ
What is the percentage of profitable transactions made by Douglas Norman Deeth?
The percentage of profitable transactions made by Douglas Norman Deeth is ―.
What is the average return per transaction made by Douglas Norman Deeth?
The average return per transaction made by Douglas Norman Deeth is ―.
What stocks does Douglas Norman Deeth hold?
Douglas Norman Deeth holds: CXRXF, CPHRF stocks.
What was Douglas Norman Deeth’s latest transaction?
Douglas Norman Deeth latest transaction was an Uninformative Sell of $40.90K.
What was Douglas Norman Deeth's most profitable transaction?
Douglas Norman Deeth’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Douglas Norman Deeth's role in ADVANZ PHARMA?
Douglas Norman Deeth's role in ADVANZ PHARMA is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.